James Campbell
Impact in
- Oncology top 2%
- PARP inhibition in cancer therapy
- Cancer-related Molecular Pathways
- Molecular Biology top 5%
- DNA Repair Mechanisms
- CRISPR and Genetic Engineering
- Genomics and Chromatin Dynamics
- Chromatin Remodeling and Cancer
Papers in
-
- CRISPR and Genetic Engineering 6
- Genomics and Chromatin Dynamics 5
- Oncology 20
- PARP inhibition in cancer therapy 8
- Cancer-related Molecular Pathways 6
- Co-authors
- Christopher J. Lord (21 shared papers)Alan Ashworth (14 shared papers)Kerry Fenwick (8 shared papers)Iwanka Kozarewa (8 shared papers)Rachel Brough (9 shared papers)Ioannis Assiotis (5 shared papers)Lina Chen (5 shared papers)Asha Konde (5 shared papers)
- Journals
- Molecular Cancer Therapeutics (4 papers)The Journal of Pathology (3 papers)PROTEOMICS (3 papers)PLoS ONE (3 papers)Nature Communications (2 papers)
- Partner nations
- United KingdomUnited StatesIreland
In The Last Decade
James Campbell
59 papers receiving 3.3k citations
Peers
Comparison fields: 5 of 139
- Oncology 1.2k
- Molecular Biology 2.1k
- Cancer Research 374
- Biological Psychiatry 60
- Reproductive Medicine 179
Countries citing papers authored by James Campbell
This map shows the geographic impact of James Campbell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Campbell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Campbell more than expected).
Fields of papers citing papers by James Campbell
This network shows the impact of papers produced by James Campbell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Campbell. The network helps show where James Campbell may publish in the future.
Co-authors
The 25 scholars most cited alongside James Campbell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 353 | |
| 2 | 2013 | 279 | |
| 3 | 2012 | 271 | |
| 4 | 2016 | 270 | |
| 5 | 2013 | 184 | |
| 6 | 2014 | 174 | |
| 7 | 2012 | 148 | |
| 8 | 2013 | 142 | |
| 9 | 2013 | 98 | |
| 10 | 2011 | 98 | |
| 11 | 2012 | 89 | |
| 12 | 2017 | 64 | |
| 13 | 2020 | 64 | |
| 14 | 2010 | 64 | |
| 15 | 2017 | 60 | |
| 16 | 2017 | 58 | |
| 17 | 2016 | 58 | |
| 18 | 2018 | 54 | |
| 19 | 2011 | 53 | |
| 20 | 2014 | 51 |
About James Campbell
James Campbell is a scholar working on Molecular Biology, Oncology, Physiology, Genetics and Spectroscopy, having authored 61 papers that have together received 3.3k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (8 papers), Advanced Proteomics Techniques and Applications (7 papers), Alzheimer's disease research and treatments (6 papers), CRISPR and Genetic Engineering (6 papers), Cancer-related Molecular Pathways (6 papers), Healthcare Policy and Management (5 papers), Cancer Genomics and Diagnostics (5 papers) and Genomics and Chromatin Dynamics (5 papers). The work is most often cited by research in Oncology (1.2k citations), Molecular Biology (2.1k citations), Cancer Research (374 citations), Biological Psychiatry (60 citations) and Reproductive Medicine (179 citations). James Campbell has collaborated with scholars based in United Kingdom, United States and Ireland. Frequent co-authors include Christopher J. Lord, Alan Ashworth, Kerry Fenwick, Iwanka Kozarewa, Rachel Brough, Ioannis Assiotis, Lina Chen, Asha Konde, Florent Elefteriou and Julie A. Sterling. Their work appears in journals such as Molecular Cancer Therapeutics, The Journal of Pathology, PROTEOMICS, PLoS ONE and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.